Blood biomarker changes and relationships after low dose oral ketamine treatment for post-traumatic stress disorder (PTSD).
Confidence:
0.12
Neurotrophic Modulation Restores Motor and Developmental Defects in Zebrafish Models of ints11 Deficiency.
Confidence:
0.16
Targeted muscle reinnervation attenuates neuropathic pain and neuroma development in a rat model of tibial nerve transection.
Confidence:
0.1
PDE1B and PDE10A as novel targets for schizophrenia: from molecular design and synthesis to therapeutic promise.
Confidence:
0.2
Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.
Confidence:
0.07
Synergistic Roles of Neuropeptide S and Environmental Enrichment in Preclinical Huntington's Disease Depression Models.
Confidence:
0.18
Aloe Polysaccharides against 3-Nitropropionic acid-induced Huntington's disease-like symptoms: Role of BDNF/NF-ฮบB/Nrf2 signaling pathways.
Confidence:
0.16
Long non-coding SINEUP RNA enhancing BDNF translation prevents dendritic atrophy following an Aฮฒ-peptide challenge.
Confidence:
0.11
Effects of 16-week aerobic exercise and whole-body vibration on myokines and neurocognitive indices in postmenopausal women: A randomized control study.
Confidence:
0.03
Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.
Confidence:
0.04
A Preliminary Research: Effect of Pleasant and Unpleasant Food Odors on the Health of Mice Through Olfaction.
Confidence:
0.07
Gut-Brain Metabolic Remodeling Mediates the Neuroprotective Effects of Combined Shrimp and Corn Peptides in Scopolamine-Induced Cognitive Impairment.
Confidence:
0.09
Neuroprotective Effect of the Combined Extract of
Confidence:
0.09